相关实验视频

Updated: Jul 16, 2026

Application of Light-cured Dental Adhesive Resin for Mounting Electrodes or Microdialysis Probes in Chronic Experiments
16:30

Application of Light-cured Dental Adhesive Resin for Mounting Electrodes or Microdialysis Probes in Chronic Experiments

Published on: July 30, 2007

15.4K

在非性宫病变中,延长应用时间对通用粘合剂的影响:一个为期18个月的分口随机临床试验

Rab De Almeida1, Fsf Siqueira1, Thiago Verde1

  • 1Department of Postgraduate Program in Dentistry, CEUMA University, São Luis, Maranhão, Brazil.

Journal of dentistry
|December 6, 2023
PubMed
概括

克莱尔菲尔 (Clearfil Universal Bond Quick) 在18个月的时间内在非性子宫病变中表现出色的临床性能,无论应用时间如何. 这种新的通用粘合剂的性能与Clearfil SE Bond相美,使用无等待技术显示出有希望的结果.

关键词:
粘合剂是一种粘合剂.外国直接投资标准 外国直接投资标准没有等待技术.没有的宫病变.

更多相关视频

Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites07:04

Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites

Published on: November 9, 2014

13.6K
Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material07:42

Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material

Published on: December 20, 2024

410

相关概念视频

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.